Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design

被引：30

作者：

Venkatraman, S ^{[1
]}

Njoroge, FG ^{[1
]}

Girijavallabhan, VM ^{[1
]}

Madison, VS ^{[1
]}

Yao, NH ^{[1
]}

Prongay, AJ ^{[1
]}

Butkiewicz, N ^{[1
]}

Pichardo, J ^{[1
]}

机构：

[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 16期

关键词：

D O I：

10.1021/jm0489556

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Hepatitus C virus (HCV) NS3, when bound to NS-4A cofactor, facilitates development of mature virons by catalyzing cleavage of a polyprotein to form functional and structural proteins of HCV. The enzyme has a shallow binding pocket at the catalytic site, making development of inhibitors difficult. We have designed, preorganized, and depeptidized macrocyclic inhibitors from P-4 to P-2' and optimized binding to 0.1 mu M. The structure of an inhibitor bound to the enzyme was also solved.

引用

页码：5088 / 5091

页数：4

共 50 条

[21] Structure-based design of macrocyclic kinase inhibitors [J].

Poulsen, Anders ;

Wiliam, Anthony D. ;

Blanchard, Steephanie ;

Dymock, Brian .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246

[22] Determinants for Substrate Selectivity of the Hepatitis C Virus NS3-4A Protease [J].

Tran, Huong T. L. ;

Gouttenoire, Jerome ;

Moradpour, Darius .

SWISS MEDICAL WEEKLY, 2013, 143 :8S-8S

[23] Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors [J].

Letitia Shunmugam ;

Pritika Ramharack ;

Mahmoud E. S. Soliman .

The Protein Journal, 2017, 36 :397-406

[24] Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors [J].

Shunmugam, Letitia ;

Ramharack, Pritika ;

Soliman, Mahmoud E. S. .

PROTEIN JOURNAL, 2017, 36 (05) :397-406

[25] Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase [J].

Beran, Rudolf K. F. ;

Pyle, Anna Marie .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (44) :29929-29937

[26] Structure-based design of parasitic protease inhibitors [J].

Li, RS ;

Chen, XW ;

Gong, BQ ;

Selzer, PM ;

Li, Z ;

Davidson, E ;

Kurzban, G ;

Miller, RE ;

Nuzum, EO ;

McKerrow, JH ;

Fletterick, RJ ;

Gillmor, SA ;

Craik, CS ;

Kuntz, ID ;

Cohen, FE ;

Kenyon, GL .

BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (09) :1421-1427

[27] STRUCTURE-BASED DESIGN OF ASPARTYL PROTEASE INHIBITORS [J].

THAISRIVONGS, S .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 :20-CINF

[28] Discovery of novel allosteric inhibitors of HCV NS3/4a enzyme via structure-based drug design Discovery of novel allosteric inhibitors of HCV NS3/4a enzyme via structure-based drug design [J].

Pathuri, Puja ;

Saalau-Bethell, Susanne M. ;

Woodhead, Andrew J. ;

Carr, Maria G. ;

Chessari, Gianni ;

Coyle, Joseph ;

Frederickson, Martyn ;

Graham, Brent ;

Hamlett, Chris ;

Hiscock, Steven D. ;

Holding, Finn P. ;

Jhoti, Harren ;

McMenamin, Rachel ;

Murray, Chris W. ;

Reader, Mike ;

Rees, David C. ;

Rich, Sharna J. ;

Richardson, Caroline J. ;

Thompson, Neil ;

Verdonk, Marcel L. ;

Vinkovic, Mladen ;

Williams, Pamela A. ;

Yon, Jeff .

ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2012, 68 :S27-S27

[29] Searching for Novel Cellular Targets of the Hepatitis C Virus NS3-4A Protease [J].

Morikawa, Kenichi ;

Gouttenoire, Jerome ;

Bellecave, Pantxika ;

Lange, Christian M. ;

Kennel, Audrey ;

Quadroni, Manfredo ;

Moradpour, Darius .

SWISS MEDICAL WEEKLY, 2011, 141 :19S-19S

[30] Synthesis of cyclopropyl peptidomimetics as potential BACE and HCV NS3-4a protease inhibitors [J].

Dunlap, Norma ;

Gouger, Daniel H. ;

Carter, Christine ;

Alemayehu, Biruk .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243

← 1 2 3 4 5 →